Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
By delivering gene therapies to patients before they go blind, doctors may be able to prevent the loss of many important light-detecting cells.
A stem-cell startup aims to test neural stem cells for treating two leading causes of blindness.
Gene therapy to make cells sensitive to light takes a step toward clinical use.
Delivering light-sensitive proteins to the retinas of blind mice restores some vision.
Photoreceptors created from induced pluripotent stem cells.
Researchers stimulate the growth of new retinal cells in mice.
From millions of random mutations, scientists identify a virus that could make gene therapy for inherited retinal diseases safer and more effective.
The technique would retrain cells that typically don’t respond to light.
Treatment leads to an unexpected improvement in vision for one patient.
A novel medical device could treat eye diseases like age-related macular degeneration.